Search Bar & Filters
Found 7 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating surgical methods to treat chronic oroantral fistulas COAF, which are abnormal openings between the mouth and maxillary sinus that tend to recur. This study focuses on comparing a hinge flap technique combined with a buccal advancement flap against the traditional palatal flap method to improve closure success in the most posterior maxilla area. The trial aims to reduce recurrence rates and postoperative complications by reinforcing local tissue flaps during surgery. Participants will be randomly assigned to one of two groups the experimental group receiving the hinge flap with buccal advancement flap, and the control group treated with an anteriorly based palatal rotational flap. The hinge flap involves a circular incision around the fistula to close the sinus membrane and reinforce the buccal flap. The palatal flap uses incisions on the palate with ligation of vessels to reposition tissue over the fistula. Both procedures seek to close the oroantral fistula surgically. During the study, participants will undergo surgery followed by monitoring for recurrence, surgical difficulties, and time taken for the procedure. Researchers will assess outcomes like fistula closure success and patient satisfaction four months postoperatively. This triple-blinded trial ensures unbiased evaluation of the two surgical techniques, with a total study duration extending to 2028. Participants can expect follow-up evaluations to track healing and complications after their surgery.
Actively Recruiting
Healthy Volunteer
Researchers are comparing the effectiveness of two different volumes of buccal infiltration of Articaine for extracting mandibular posterior teeth. This trial aims to evaluate whether 1.8 ml or 3.6 ml of 4% Articaine provides better anesthesia and pain control during tooth extraction. The study addresses concerns with the common inferior alveolar nerve block technique, which can cause complications such as pain, facial nerve paralysis, and other side effects. Participants will be randomly assigned to receive either 1.8 ml or 3.6 ml of 4% Articaine via buccal infiltration. This method is considered safer and less painful than the traditional nerve block. The trial compares these two doses to determine their effectiveness in providing adequate anesthesia for painless extraction of mandibular posterior teeth. During the study, participants will be assessed for pain intensity from reflection of the mucoperiosteum until the tooth is removed, the time it takes for anesthesia to begin up to 10 minutes, and the presence or absence of pain throughout the procedure. The research team will monitor these outcomes to understand which volume of Articaine offers better pain control and faster anesthesia onset during dental extraction.
Actively Recruiting
Researchers are evaluating whether carbetocin alone is as effective as carbetocin combined with supplemental oxytocin infusion in preventing the need for additional uterotonic agents after elective cesarean delivery. This study addresses the uncertainty about whether adding oxytocin provides extra benefit or may be redundant or counterproductive due to receptor desensitization. The trial is a prospective, randomized, double-blind, placebo-controlled non-inferiority study with a pilot phase, involving women aged 18 to 45 undergoing elective cesarean delivery. Participants are assigned to one of two groups one receives carbetocin 100 micrograms intravenously as a single bolus followed by a placebo saline infusion over 4 hours the other receives the same carbetocin bolus followed by an oxytocin infusion 10 IU in saline over 4 hours. Both treatments are administered immediately after umbilical cord clamping under spinal anesthesia. The trial includes a standardized fluid protocol for all participants. During the study, researchers monitor the need for additional uterotonic agents within 24 hours as the primary outcome. Secondary outcomes include detailed measurements of blood loss using gravimetric and formula-based methods, uterine tone assessed at specific intervals, incidence of postpartum hemorrhage and blood transfusions, hemodynamic profiles, and adverse effects. Monitoring continues for 24 hours post-delivery with frequent vital sign assessments and blood tests. The total study duration covers the immediate perioperative period and 24-hour postoperative follow-up.
Actively Recruiting
This research evaluates the effectiveness and safety of two dosing methods for colistin, an antibiotic used to treat infections caused by multi-drug-resistant and extensively drug-resistant Gram-negative bacteria in critically ill patients. These infections, especially common in intensive care units, pose a significant threat due to increasing antibiotic resistance, particularly in Saudi Arabia. The study focuses on comparing fixed dose and weight-based dose strategies in both obese and non-obese patients. Participants will be randomly assigned to one of two groups. One group receives intravenous colistin using a fixed dose strategy based on creatinine clearance, with a loading dose of 9 MIU equal to 300 mg of colistin base activity followed by maintenance doses every 12 hours. The other group receives colistin dosed based on body weight, with a loading dose calculated as four times the patients weight in kilograms, which may exceed 300 mg. Both dosing strategies will be administered intravenously in the intensive care unit setting. During the study, patients will be monitored for clinical and microbiological success in eliminating infections, assessed 14 days after starting colistin treatment. Safety will also be closely watched, particularly for kidney-related side effects. Researchers will collect data on how well the infection is cleared and observe any toxic effects from the treatment. The trial will last throughout the treatment period and follow-up to assess outcomes and safety in critically ill patients.
Actively Recruiting
Retinopathy of prematurity ROP is a serious eye condition affecting premature infants and can lead to childhood blindness. This research evaluates the occurrence and severity of low oxygen levels hypoxia during bedside injections of ranibizumab, a treatment for ROP, in premature infants across multiple hospitals in the Al Qassim region of Saudi Arabia. The study aims to fill a knowledge gap about breathing problems during these injections under topical anesthesia in this vulnerable population. The study looks at infants who received intravitreal ranibizumab injections at the bedside in neonatal intensive care units NICUs from July 2020 through June 2026. The injections use a standard protocol involving a small needle, antiseptic application, and close follow-up for 1 to 2 weeks after treatment. Oxygen levels are continuously monitored with pulse oximetry during and shortly after the procedure to detect hypoxia, which is classified by severity. Data collected includes demographic, maternal, perinatal, and treatment details. Participants oxygen saturation and other vital signs are monitored closely during the procedure to identify any drops in oxygen levels. Researchers analyze these events along with patient and treatment factors to understand risks. The primary outcome measures the occurrence of hypoxia within one year. The study uses retrospective data and includes follow-up information to assess safety and incidence of low oxygen events during and after ranibizumab injections for ROP.
Actively Recruiting
Researchers are studying adults aged 18 to 60 years undergoing elective septoplasty with severe nasal obstruction, a condition causing chronic mouth breathing and pharyngeal mucosal dehydration. This group is at higher risk for postoperative sore throat POST after general anesthesia with endotracheal intubation. The study is a double-blind randomized controlled trial aiming to evaluate whether a new mucosal conditioning method can reduce POST incidence and severity compared to standard care. Participants are randomly assigned to one of two groups. The intervention group receives nebulized 0.9% normal saline 30 minutes before anesthesia along with a water-soluble lubricant gel applied to the endotracheal tube. The control group receives a sham nebulization with room air and plain water on the tube. Both groups follow standardized anesthetic protocols with propofol, fentanyl, rocuronium, and sevoflurane. The study monitors effects before and after nebulization and uses a throat pack during surgery. During the trial, participants are assessed for sore throat incidence one hour after extubation by a blinded nurse. Researchers also measure sore throat severity at 1, 6, and 24 hours, hoarseness, swallowing difficulties, nausea and vomiting, and time to first pain medication. Preoperative mucosal hydration is evaluated using the Modified Schirmer Test and dryness scores. Patient satisfaction and correlations between nasal obstruction severity and POST are also recorded. The total study duration includes assessments up to 24 hours post-extubation.
Actively Recruiting
Maxillary sinusitis caused by dental or dento-alveolar structural problems, known as odontogenic maxillary sinusitis OMS, requires a distinct treatment approach compared to other types of sinusitis. This condition involves different causes, diagnosis, and treatments, and there is no clear consensus among specialists such as otolaryngologists, maxillofacial surgeons, and dentists on the best treatment method or which specialist should lead the care. This study aims to evaluate the effectiveness of a combined approach using Single-step Functional Sinus Endoscopy and transoral surgery for treating OMS through an integrated departmental therapy. Participants will be treated in one of three groups the combined Single-step Functional Sinus Endoscopy and transoral surgery group, where functional sinus endoscopy is performed by an otolaryngologist and transoral surgery by an oral and maxillofacial surgeon in the same visit a group treated only with functional sinus endoscopy by the otolaryngologist and a group treated only with transoral surgery by the oral and maxillofacial surgeon. The transoral procedures involve tooth extraction, fistula closure, or cyst removal, while the sinus endoscopy involves cleaning and irrigating the sinus under general anesthesia. Throughout the study, participants will be monitored by measuring the thickness of the sinus mucosa at two weeks, one month, and three months after the intervention. Clinical, radiographic, and endoscopic sinus surgery ESS data will be collected to assess outcomes. The research team will use these measurements to evaluate treatment effectiveness and safety. The study is randomized and double-blinded, with an expected completion date in July 2027.